Browsing by Author Kannan, Srinivasaraghavan

Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)
2018Conformational landscape of the epidermal growth factor receptor kinase reveals a mutant specific allosteric pocketKannan, Srinivasaraghavan; Venkatachalam, Gireedhar; Lim, Hong Hwa; Surana, Uttam; Verma, Chandra
2019The dual interactions of p53 with MDM2 and p300 : implications for the design of MDM2 inhibitorsKannan, Srinivasaraghavan; Partridge, Anthony William; Lane, David P.; Verma, Chandra Shekhar
2017Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinibKannan, Srinivasaraghavan; Pradhan, Mohan R.; Tiwari, Garima; Tan, Wei-Chong; Chowbay, Balram; Tan, Eng Huat; Tan, Daniel Shao-Weng; Verma, Chandra
2019Inhibiting S100B(ββ) for activating wild-type p53 : design of stapled peptidesKannan, Srinivasaraghavan; Aronica, Pietro G. A.; Tan, Yaw Sing; Verma, Chandra Shekhar
2016Long range recognition and selection in IDPs : the interactions of the C-terminus of p53Kannan, Srinivasaraghavan; Lane, David P.; Verma, Chandra Shekhar
 2014mAb806 binding to epidermal growth factor receptor: a computational studyNg, Yao Zong; Kannan, Srinivasaraghavan; Lane, David P.; Fuentes, Gloria; Verma, Chandra Shekhar
2015Mussel adhesion is dictated by time-regulated secretion and molecular conformation of mussel adhesive proteinsPetrone, Luigi; Kumar, Akshita; Sutanto, Clarinda N.; Patil, Navinkumar J.; Kannan, Srinivasaraghavan; Palaniappan, Alagappan; Amini, Shahrouz; Zappone, Bruno; Verma, Chandra; Miserez, Ali
 2018Optimization of selective mitogen-activated protein kinase interacting kinases 1 and 2 inhibitors for the treatment of blast crisis leukemiaYang, Haiyan; Chennamaneni, Lohitha Rao; Ho, Melvyn Wai Tuck; Ang, Shi Hua; Tan, Eldwin Sum Wai; Jeyaraj, Duraiswamy Athisayamani; Yeap, Yoon Sheng; Liu, Boping; Ong, Esther H. Q.; Joy, Joma Kanikadu; Wee, John Liang Kuan; Kwek, Perlyn; Retna, Priya; Dinie, Nurul; Nguyen, Thuy Thi Hanh; Tai, Shi Jing; Manoharan, Vithya; Pendharkar, Vishal; Low, Choon Bing; Chew, Yun Shan; Vuddagiri, Susmitha; Sangthongpitag, Kanda; Choong, Meng Ling; Lee, May Ann; Kannan, Srinivasaraghavan; Verma, Chandra Shekhar; Poulsen, Anders; Lim, Sharon; Chuah, Charles Thuan Heng; Ong, Tiong Sin; Hill, Jeffrey; Matter, Alex; Nacro, Kassoum
2019Preclinical characteristics of the irreversible pan-HER kinase inhibitor neratinib compared with lapatinib : implications for the treatment of HER2-positive and HER2-mutated breast cancerCollins, Denis M.; Conlon, Neil T.; Kannan, Srinivasaraghavan; Verma, Chandra Shekhar; Eli, Lisa D.; Lalani, Alshad S.; Crown, John
 2015Probing the Binding Mechanism of Mnk Inhibitors by Docking and Molecular Dynamics SimulationsKannan, Srinivasaraghavan; Poulsen, Anders; Yang, Hai Yan; Ho, Melvyn; Ang, Shi Hua; Eldwin, Tan Sum Wai; Jeyaraj, Duraiswamy Athisayamani; Chennamaneni, Lohitha Rao; Liu, Boping; Hill, Jeffrey; Verma, Chandra Shekhar; Nacro, Kassoum
2019Simulations of mutant p53 DNA binding domains reveal a novel druggable pocketSiau, Jia Wei; Kannan, Srinivasaraghavan; Ouaray, Zohra; Kwoh, Chee Keong; Ghadessy, Farid; Pradhan, Mohan Rajan; Nguyen, Minh N.; Lane, David P.; Verma, Chandra Shekhar